Skip to Main Content

Try STAT+ TODAY

women’s health

Most Read

First Opinion Leslie Farrington

How the CDC and others are failing Black women during childbirth

First Opinion Divya Dethier, Megan L. Evans and Erin Tracy Bradley

Medicaid needs to change its archaic rules for women seeking permanent contraception

First Opinion Oni Blackstock

Barring cisgender women from the Descovy trials was a bad call

First Opinion Adam C. Urato

The FDA must pull Makena off the market

Health Sharon Begley

From assisted hatching to embryo glue, most IVF ‘add-ons’ rest on shaky science, studies find

Health Helen Branswell

Large numbers of pregnant women not getting key vaccines, CDC says

First Opinion Amy Compton-Phillips

5 things hospitals can do today to keep women from dying during childbirth

Health Megan Thielking

‘I wanted to trust my body’: Against doctors’ recommendations, some pregnant women refuse ultrasounds

All Coverage

Pharmalot Ed Silverman

STAT Plus: FDA and Covis release dueling documents over the fate of a controversial drug for premature births

First Opinion Vineeta Gupta and Philippa Whitford

Investing in women, children, and nutrition is not optional. The world’s future depends on it

advertisement

First Opinion Tanika Gray Valbrun

Uterine fibroids affect millions of women. Why has this condition been overlooked for decades?

Biotech Kate Sheridan

STAT Plus: Flagship-backed fertility company Ohana Biosciences shutters, lays off most employees

First Opinion Laura E. Riley and Brenna L. Hughes

Pregnant and lactating women should not be excluded from Covid-19 drug, vaccine trials

First Opinion Ushma D. Upadhyay

The FDA approved the abortion pill 20 years ago. It’s time to make it available via telehealth

First Opinion Alexander Borsa, Joseph Bruch and Sarah S. Richardson

When private equity firms invest in women’s health clinics, who benefits?

Health Alice Proujansky

Pregnancy poses challenges for people in recovery from substance use disorder. Covid-19 is taxing their support system

First Opinion Melinda Gates

Sexist and incomplete data hold back the world’s Covid-19 response

First Opinion Eva Luo, Toni Golen and Alexa B. Kimball

Rising to the challenge of screening for intimate partner violence during Covid-19

Biotech Elizabeth Cooney

STAT Plus: Myovant endometriosis drug meets its goal in a second late-stage trial, company says

First Opinion Saralyn Mark

Account for gender/sex to make personal protective equipment safer for women

In the Lab Elizabeth Cooney

Females are still routinely left out of biomedical research — and ignored in analyses of data

First Opinion Emma McKim Mitchell

All women should have access to the at-home test that can provide early detection of cervical cancer

First Opinion Laurie Zephyrin

The challenges of giving birth in the time of Covid-19

Health Megan Thielking

STAT Plus: How to rebrand a research study? For one project, Instagram influencers and a dash of wit go a long way

First Opinion Adam Wolfberg

It will take a village to solve the epidemic of maternal deaths in the U.S.

First Opinion Robert Klitzman

Paying gestational carriers should be legal in all states

Business Matthew Herper

Merck to spin off new $6.5 billion firm focused on women’s health, older drugs

First Opinion Tracey Wilkinson

Abortion advice should be as safe as abortion itself

Biotech Kate Sheridan

STAT Plus: ‘The gurus of sperm’: Ohana Biosciences is taking a different approach to fertility

First Opinion Jennifer Gunter

Goop’s pseudoscience ministry comes to Netflix

Health Megan Thielking

As more states legalize marijuana, pregnant women and their doctors grapple with how to talk about it

Health Matthew Herper

STAT Plus: Breast cancer drug picked up by AstraZeneca shrinks tumors in majority of women with common tumor

Health Associated Press

A monthly birth control pill? Experiment in pigs opens door to more trials